This report contains market size and forecasts of Hereditary Angioedema Treatment in global, including the following market information:
Global Hereditary Angioedema Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hereditary Angioedema Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hereditary Angioedema Treatment companies in 2021 (%)
The global Hereditary Angioedema Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hereditary Angioedema Treatment include CSL, Pharming Group, Shire plc (Takeda Pharmaceutical Company Limited), Ionis Pharmaceuticals, Attune Pharmaceuticals, BioCryst Pharmaceuticals and KalVista Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hereditary Angioedema Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Angioedema Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hereditary Angioedema Treatment Market Segment Percentages, by Type, 2021 (%)
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Global Hereditary Angioedema Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hereditary Angioedema Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Global Hereditary Angioedema Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hereditary Angioedema Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hereditary Angioedema Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hereditary Angioedema Treatment revenues share in global market, 2021 (%)
Key companies Hereditary Angioedema Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hereditary Angioedema Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals